AUTO-T Trademark
AUTO-T is a USPTO trademark filed by NATIONAL RESILIENCE, LLC. Status: Pending.
Trademark Facts
| Mark | AUTO-T |
|---|---|
| Serial Number | 98667079 |
| Status | Pending |
| Filing Date | 2024-07-25 |
| Mark Type | Word |
| Nice Classes | 040 (Material Treatment), 042 (Software & IT) |
| Owner | NATIONAL RESILIENCE, LLC |
| Attorney of Record | Susan M. Natland |
| Prosecution Events | 30 |
| Latest Event | EXRA on 2026-03-03 |
Goods & Services
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology; providing technical information about biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; Research and development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; design and development of technology platforms, namely, biomanufacturing relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; provision of information relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services in the nature of development of new technology for others in the field of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; design and development of biomanufacturing platforms for others, namely, product development for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process